News
-

Should I Take NAD+? A Provider's Decision Path
The answer starts with your goal and what is causing the tiredness. Oral supplement findings don't establish what NAD+ injections would do for you.
-

What Does A1C Reduction Mean? A One-Point Drop
A one-point A1C drop means about 29 mg/dL less estimated average blood sugar. Its meaning depends on the starting number and how safely it falls.
-

Forzinity Prescribing Information: Plain English
Forzinity’s label covers Barth syndrome, a daily injection, and specific safety limits. Here’s what each section means.
-

GHK-Cu Myths: 8 Claims Checked Against Evidence
GHK-Cu has real human research on skin and wounds. That doesn't establish that injections make people younger, regrow hair, or work like a cream.
-

Semax Side Effects: What the Safety Data Shows
Mild nasal irritation is documented, but reliable rates for other reactions are missing. The small studies leave important safety questions unanswered.
-

STEP UP Trial Results: 7.2 mg Versus 2.4 mg
STEP UP compared two semaglutide doses with placebo over 72 weeks. The higher dose brought more weight loss and more stomach and skin symptoms.
-

Tirzepatide and Pancreatitis: Risk and Symptoms
Pancreatitis is uncommon in tirzepatide trials, but it remains a serious warning. Persistent or severe stomach pain needs urgent medical attention.
-

Who Discovered Thymosin Alpha 1? Goldstein’s Team
Goldstein, White and Slater reported thymosin in 1966. A larger team isolated alpha-1 in 1977, opening the path to synthetic thymalfasin and Zadaxin.
-

Semaglutide and Gallbladder: Risks and Symptoms
Gallstones were more common in semaglutide trials, but most participants did not report them. Here are the Wegovy and Ozempic rates and the symptoms that need urgent care.
-

Semaglutide and Menopause: Weight, HRT and Bone
Semaglutide may help with medically appropriate weight management after menopause. Hormone therapy, muscle, bone, and menopause symptoms each need their own place in the care plan.
-

STEP-HFpEF Results: Symptoms, Weight and Limits
Semaglutide improved symptoms and walking distance in two year-long trials of adults with obesity and heart failure. Here are the results, side effects and limits.
-

SURPASS-CVOT Results: What the Heart Trial Found
Tirzepatide met the trial’s standard for not being meaningfully worse than dulaglutide. It did not establish better heart outcomes.
-

Semaglutide for PCOS: Weight Loss and Periods
Semaglutide may help with weight loss in some people with PCOS. Evidence for more regular periods is growing, while pregnancy plans change the decision.
-

Semaglutide for Sleep Apnea: What Studies Show
Semaglutide may help with weight management when obesity contributes to sleep apnea. It isn't approved to treat sleep apnea and doesn't replace prescribed CPAP.
-

SURMOUNT-3 Results: More Weight Loss After Diet
After an average 6.9% loss through diet and exercise, selected trial participants lost another 18.4% on tirzepatide. Participants receiving an injection without tirzepatide gained 2.5% over the same 72 weeks.
-

NAD+ Myths: 7 Claims Checked Against the Evidence
Some swallowed supplements raise blood NAD+. That doesn't show injections make people younger or that a drip into a vein works better than a shot.
-

10 Questions to Ask Before Starting Sermorelin
A sermorelin visit covers the goal, health history, labs, and a practical follow-up plan. These ten questions explain why each part matters and what a clear answer includes.
-

Should I Take MOTS-c? Start With These Questions
MOTS-c isn't an established treatment for weight loss or tiredness. A provider weighs the thin human evidence, your medicines and sports rules before deciding whether it fits.
-

Tirzepatide and Cholesterol: What the Numbers Mean
Trials found larger changes in some blood fats than in the cholesterol linked to artery buildup. Here is what those percentages mean on a lab report.
-

Vyleesi Prescribing Information, in Plain English
Vyleesi's label covers one specific form of low desire, a fixed injection dose, and safety limits. Here are its sections in everyday language.
Page 8 of 27 · 528 articles